Detection and Control of Unannounced Exercise in the Artificial Pancreas Without Additional Physiological Signals

IEEE J Biomed Health Inform. 2020 Jan;24(1):259-267. doi: 10.1109/JBHI.2019.2898558. Epub 2019 Feb 11.

Abstract

The purpose of this study was to develop an algorithm that detects aerobic exercise and triggers disturbance rejection actions to prevent exercise-induced hypoglycemia. This approach can provide a solution to poor glycemic control during and after aerobic exercise, a major hindrance in the participation of exercise by patients with type 1 diabetes. This novel exercise-induced hypoglycemia reduction algorithm (EHRA) detects exercise using a threshold on a disturbance term, a parameter estimated from an augmented minimal model using an unscented Kalman filter. After detection, the EHRA triggers the following three actions: First, a carbohydrate suggestion, second, a reduction in basal insulin and the insulin-on-board maximum limit, and finally, a 30% reduction of the next insulin meal bolus. The EHRA was tested in silico using a 15-day scenario with 8 exercise sessions of 50 min at [Formula: see text] on alternating days. The EHRA was able to obtain improved results when compared to strategies with and without exercise announcement. The unannounced, announced, and EHRA strategies all obtained an overall percentage of time in range (70-180 mg/dl) of 94% and a percentage of time 70 mg/dl of 2%, 0%, and 0%, respectively. The EHRA was tested for robustness during exercise sessions of +25% and -25% intensity and results suggest that the EHRA is able to account for variability in exercise intensity, duration, and patient dynamics such as glucose uptake rate and insulin sensitivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Blood Glucose / analysis
  • Blood Glucose / metabolism
  • Computer Simulation
  • Diabetes Mellitus, Type 1* / metabolism
  • Diabetes Mellitus, Type 1* / physiopathology
  • Diabetes Mellitus, Type 1* / therapy
  • Exercise / physiology*
  • Humans
  • Insulin / administration & dosage
  • Insulin / therapeutic use
  • Monitoring, Physiologic
  • Pancreas, Artificial*

Substances

  • Blood Glucose
  • Insulin